The antibody drug production base "Cellularforce" officially goes into operation to promote the R & D and production of international advanced antibody drugs.

来源:本站 日期:2021-04-24

On April 24, the cdmo production base ofantibody drugs built by Jiangsu Cellularforce Biopharma Co., Ltd. (hereinafterreferred to as " Cellularforce "), a subsidiary of Qyuns, officiallygoes into operation. This antibody drug production base is established instrict accordance with the GMP standards of China NMPA, US FDA and EU EMA,achieving the integration of research, design, development, analysis, laboratory-scaletest, pilot-scale test, commercial production and other services, promoting theR & D and production of international advanced antibody drugs.